Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
They are looking at the patients from last year’s hospital P2 as well the HT patients. I’m guessing the company wants to release the long covid data in one go. May 28th 2020 was when the last P2 hospital patient was recruited so we need to pass that one year anniversary first.
If it’s shown that there’s a somewhat significant improvement in health outcomes in HT long covid results then that would be great for us. The drug won’t be beneficial in the short term for people with mild symptoms but they would still take sng001 to deal with long run health complications by decreasing the severity of them and/or decreasing the probability of them occurring. Then again, this is speculation and is contingent on the long covid analysis demonstrating this.
I thought it was known that the P3 readout is going to happen in H2 given the final recruitment date of June 1st. Now knowing they can post the primary outcome results and long covid results separately, the P3 primary outcome readout could happen around mid-July with Activ2 and P2 long covid results between now and then.